A multicenter, randomized trial comparing synthetic surfactant with modified bovine surfactant extract in the treatment of neonatal respiratory distress syndrome

Pediatrics

Volumn 97, Issue 1, 1996, Pages 1-6

  Soll, Roger F ^a  

^a UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

Author keywords

clinical trials; newborn; pulmonary surfactant; respiratory distress syndrome

Indexed keywords

LUNG SURFACTANT;

AIRWAY PRESSURE; ARTICLE; ASSISTED VENTILATION; CHRONIC LUNG DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEATH; FEMALE; HUMAN; INTRATRACHEAL DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NEWBORN; PNEUMOTHORAX; PREMATURITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY DISTRESS SYNDROME;

BIOLOGICAL PRODUCTS; CHRONIC DISEASE; DRUG COMBINATIONS; FATTY ALCOHOLS; FEMALE; HUMANS; INFANT, LOW BIRTH WEIGHT; INFANT, NEWBORN; INFANT, PREMATURE; LUNG DISEASES; MALE; OXYGEN INHALATION THERAPY; PHOSPHORYLCHOLINE; POLYETHYLENE GLYCOLS; PULMONARY SURFACTANTS; RESPIRATORY DISTRESS SYNDROME, NEWBORN; RISK;

EID: 9044225944     PISSN: 00314005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Soll RF, McQueen MC. Respiratory distress syndrome. In: Sinclair JC, Bracken MB, eds. Effective Care of the Newborn Infant. Oxford, England: Oxford University Press, 1992:325-358
2. Horbar JD, Wright EC, Onstad L, et al Decreasing mortality associated with the introduction of surfactant therapy: an observational study of neonates weighing 601-1300 grams at birth. Pediatrics. 1993;2:191-196
3. Schwartz RM, Luby AM, Scanlon JW, Kellogg RJ. Effect of surfactant on morbidity, mortality and resource use in newborn infants weighing 500-1500 g. N Engl J Med. 1994;330:1476-1480
4. Wegman ME. Annual summary of vital statistics - 1990. Pediatrics. 1991; 88:1081-1092
5. Horbar JD, Wright LL, Soll RP, et al. A multicenter randomized trial comparing two surfactants for the treatment of neonatal respiratory distress syndrome. J Pediatr. 1993,123:757-766
6. Alvarado M, Hingre R, Hakansan D, Gross S. Clinical trial of Survanta versus Exosurf in infants <1500 g with respiratory distress syndrome. Pediatr Res. 1993;33:314A. Abstract
7. Pearlman SA, Leef KM, Stefano JL, et al. A randomized controlled trial comparing Exosurf versus Survanta in the treatment of neonatal RDS Pediatr Res. 1993;33:340A. Abstract
8. Shennan AT, Dunn MS, Ohlsson A, et al. Abnormal pulmonary outcomes in premature infants prediction from oxygen requirement in the neonatal period. Pediatrics. 1988;82:527-532
9. Bell MJ, Ternberg JL, Feigin RD, et al. Neonatal necrotizing enterocolitis therapeutic decisions based upon clinical staging. Ann Surg. 1978;187. 1-7
10. Papile LA, Burstein J, Burstein R, Koffler H. Incidence and evolution of subependymal and intraventricular hemorrhage, a study of infants with birthweights less than 1500 gm. J Pediatr 1978;92:529-534
11. International Committee for the Classification of Retinopathy of Prematurity. An international classification of retinopathy of prematurity Pediatrics. 1984;74:127-133
12. SAS Institute. SAS/STAT User's Guide. Vols 1 and 2, version 6, 4th ed Cary, NC: SAS Institute; 1990
13. BMDP Statistical Software Manual. Vols 1 and 2. Berkeley, CA: University of California Press; 1988
14. Lan KKG, DeMets DL. Discrete sequential boundaries for clinical trials Biometrika 1983;70 659-663
15. The investigators of the Vermont-Oxford Trials Network Database Project. The Vermont-Oxford Trials network: very low birthweight outcomes for 1990. Pediatrics. 1993,91:540-545
16. OSIRIS collaborative group. Early vs delayed neonatal administration of a synthetic surfactant the judgment of OSIRIS. Lancet. 1992;340 1363-1369
17. Cummings JJ, Holm BA, Hudak ML, Hudak BB, Ferguson WH, Egan EA. A controlled clinical comparison of four different surfactant preparations in surfactant-deficient preterm lambs. Am Rev Respir Dis. 1992, 145:999-1004
18. Maeta H, Asakura K, Konishi M, Fujiwara T. Effect of surfactant TA on alveolar stability of premature rabbit fetus: comparison with term rabbit fetus and dry surfactant (70% DPPC and 30% PG). Acts Neonate Jap 1983;18:600
19. Tooley WH, Clements TA, Muramatsu K, et al. Lung function in prematurely delivered rabbits treated with a synthetic surfactant. Am Rev Respir Dis. 1987;136:651-656
20. Possmayer F. The role of surfactant-associated proteins. Am Rev Respir Dis. 1990;142 749-752
21. Shennan AT, Dunn MS, Ohlsson A, et al Abnormal pulmonary outcome in premature infants: prediction from oxygen requirement in the neonatal period Pediatrics. 1988;82:527-532
22. Soll RF, Sinclair JC, Bracken MB. Natural surfactant extract vs. synthetic surfactant: meta-analysis of randomized controlled trials. Pediatr Res 1995,37:374A. Abstract